RNA-Directed Actions of 8-Chloro-Adenosine in Multiple Myeloma Cells

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7968-7974

  Stellrecht, Christine M ^a   Rodriguez Jr , Carlos O ^a   Ayres, Mary ^a   Gandhi, Varsha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROCOCCAL NUCLEASE; PHOSPHODIESTERASE; RNA; URIDINE;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DISSECTION; ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MUTATION; PREMATURITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RADIOGRAPHY; RNA SYNTHESIS;

2-CHLOROADENOSINE; ADENOSINE TRIPHOSPHATE; HUMANS; MULTIPLE MYELOMA; RNA, MESSENGER; RNA, NEOPLASM; RNA, RIBOSOMAL; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 0345275863     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Langeveld, C. H., Jongenelen, C. A., Heimans, J. J., and Stoof, J. C. 8-Chloro-cyclic adenosine monophosphate, a novel cyclic AMP analog that inhibits human glioma cell growth in concentrations that do not induce differentiation. Exp. Neurol., 117: 196-203, 1992.
2. Katsaros, D., Tortora, G., Tagliaferri, P., Clair, T., Ally, S., Neckers, L., Robins, R. K., and Cho-Chung, Y. S. Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth. FEBS Lett., 223: 97-103, 1987.
3. Van Lookeren Campagne, M. M., Villalba Diaz, F., Jastorff, B., and Kessin, R. H. 8-Chloroadenosine 3′,5′-monophosphate inhibits the growth of Chinese hamster ovary and Molt-4 cells through its adenosine metabolite. Cancer Res., 51: 1600-1605. 1991.
4. Krett, N. L., Zell, J. L., Halgren, R. G., Pillay, S., Traynor, A. E., and Rosen, S. T. Cyclic adenosine-3′,5′-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma. Clin. Cancer Res., 3: 1781-1787, 1997.
5. Ally, S., Clair, T., Katsaros, D., Tortora, G., Yokozaki, H., Finch, R. A., Avery, T. L., and Cho-Chung, Y. S. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Cancer Res., 49: 5650-5655, 1989.
6. Cho-Chung, Y. S. Site-selective 8-chloro-cyclic adenosine 3′,5′-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms. J. Natl. Cancer Inst. (Bethesda), 81: 982-987, 1989.
7. Ciardiello, F., Tortora, G., Kim, N., Clair, T., Ally, S., Salomon, D. S., and Cho-Chung, Y. S. 8-Chloro-cAMP inhibits transforming growth factor α transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isof]orms which show disruption upon transformation. J. Biol. Chem., 265: 1016-1020, 1990.
8. Tortora, G., Pepe, S., Yokozaki, H., Meissner, S., and Cho-Chung, Y. S. Cooperative effect of 8-Cl-cAMP and rhGM-CSF on the differentiation of HL-60 human leukemia cells. Biochem. Biophys. Res. Commun., 177: 1133-1140, 1991.
9. Halgren, R. G., Traynor, A. E., Pillay, S., Zell, J. L., Heller, K. F., Krett, N. L., and Rosen, S. T. 8Cl-cAMP cytotoxicity in both steroid sensitive and insensitive multiple myeloma cell lines is mediated by 8Cl-adenosine. Blood, 92: 2893-2898, 1998.
10. Stellrecht, C. M., Krett, N., Ayres, M., Rosen, S., and Gandhi, V. 8-Chloro-cAMP serves as a prodrug for the RNA directed nucleoside analog, 8-chloro-adenosine. In: W. Hiddemann, T. Büchner, J. Ritter, M. Unterhalt, and T. Haferlach (eds.), Acute Leukemia IX: Basic Research, Experimental Approaches and Novel Therapies, Vol. 9, pp. 193-199. Heidelberg, Germany: Springer-Verlag, 2003.
11. Taylor, C. W., and Yeoman, L. C., Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anticancer Drugs, 3: 485-491. 1992.
12. Cummings, J., Langdon, S. P., Ritchie, A. A., Burns, D. J., Mackay, J., Stockman, P., Leonard, R. C., and Miller, W. R. Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3′,5′-monophosphate in breast cancer patients and xenograft bearing mice. Ann. Oncol., 7: 291-296, 1996.
13. Gandhi, V., Ayres, M., Halgren, R. G., Krett, N. L., Newman, R. A., and Rosen, S. T. 8-Chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res., 61: 5474-5479, 2001.
14. Dimopoulos, M. A., Kantarjian, H. M., Estey, E. H., and Alexanian, R. 2-Chlorodeoxyadenosine in the treatment of multiple myeloma. Blood, 80: 1626, 1992.
15. Barlogie, B., and Gale, R. P. Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts. Am. J. Med., 93: 443-450. 1992.
16. Goldman-Leikin, R. E., Salwen, H. R., Herst, C. V., Variakojis, D., Bian, M. L., Le Beau, M. M., Selvanayagan. P., Marder, R., Anderson, R., Weitzman, S., et al. Characterization of a novel myeloma cell line. MM. 1. J. Lab. Clin. Med., 113: 335-345, 1989.
17. Gandhi, V., Danhauser, L., and Plunkett, W. Separation of 1-β-D-arabinofuranosyl-cytosine 5′-triphosphate and 9-β-D-arabinofuranosyl-2-fluoroadenine 5′-triphosphate in human leukemia cells by high-performance liquid chromatography. J. Chromatogr., 413: 293-299, 1987.
18. Xie, C., and Plunkett, W. Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-adenine in human lymphoblastoid cells. Cancer Res., 55: 2847-2852, 1995.
19. Sherman, P. A., and Fyfe, J. A. Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem., 180: 222-226, 1989.
20. Stellrecht, C. M., Fraizer, G., Selvanayagam, C., Chao, L. Y., Lee, A., and Saunders, G. F. Transcriptional regulation of a hematopoietic proteoglycan core protein gene during hematopoiesis. J. Biol. Chem., 268: 4078-4084, 1993.
21. Rodriguez, C. O., Stellrecht, C. M., and Gandhi, V. Mechanisms for T-cell selective cytotoxicity of arabinosylguanine. Blood, 102: 1842-1848, 2003.
22. Friesen, C., Herr, I., Krammer, P. H., and Debatin, K. M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2: 574-577, 1996.
23. Stellrecht, C. M., and Gandhi, V. Concurrent isolation of ribosomal, messenger, and low molecular weight RNA. BioTechniques, 33: 1122-1124, 2002.
24. Cohen, S. S., and Plunkett, W. The utilization of nucleotides by animal cells. Ann. N. Y. Acad. Sci., 255: 269-286, 1975.
25. Gandhi, V., Chen, W., Ayres, M., Rhie, J. K., Madden, T. L., and Newman, R. A. Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats. Cancer Chemother. Pharmacol., 50: 85-94, 2002.
26. Suhadolnik, R. J. Naturally occurring nucleoside and nucleotide antibiotics. Prog. Nucleic Acid Res. Mol. Biol., 22: 193-291, 1979.
27. Lindell, T. J., Weinberg, F., Morris, P. W., Roeder, R. G., and Rutter, W. R. Specific inhibition of nuclear RNA polymerase 11 by α-amanitin. Science (Wash. DC), 170: 447-449, 1970.
28. Chodosh, L. A., Fire, A., Samuels, M., and Sharp, P. A. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase 11 in vitro. J. Biol. Chem., 264: 2250-2257, 1989.
29. Scherrer, K., Latham, H., and Darnell, J. E. Demonstration of an unstable RNA and of a precursor to ribosomal RNA in HeLa cells. Proc. Natl. Acad. Sci. USA. 49: 240-248, 1963.
30. Cooper, H. L. Degradation of 28S RNA late in ribosomal RNA maturation in nongrowing lymphocytes and its reversal after growth stimulation. J. Cell Biol. 59: 250-254, 1973.
31. Horowitz, B., Goldfinger, B. A., and Marmur, J. Effect of cordycepin triphosphate on the nuclear DNA-dependent RNA polymerase, and poly(A) polymerase from the yeast, Saccharomyces cerevisiae. Arch. Biochem. Biophys., 172: 143-148, 1976.
32. Keshgegian, A. A., Tsou, K. C., and Furth, J. J. Inhibition of mammalian polyadenylate polymerase by 2-aza-1, N6-etheno-adenosine triphosphate. Cancer Res., 36: 3151-3155, 1976.
33. Ghoshal, K., and Jacob, S. T. Ara-ATP impairs 3′-end processing of pre-mRNAs by inhibiting both cleavage and polyadenylation. Nucleic Acids Res., 19: 5871-5875, 1991.
34. Rose, K. M., Bell, L. E., and Jacob, S. T. Selective inhibition of initial polyadenylation in isolated nuclei by low levels of cordycepin 5′-triphosphate. Biochim. Biophys. Acta, 475: 548-552, 1977.
35. Abelson, H. T., Johnson, L. F., Penman, S., and Green, H. Changes in RNA in relation to growth of the fibroblast: II. The Lifetime of mRNA, rRNA, and tRNA in resting and growing cells. Cell, 1: 161-165, 1974.
36. Cooper, H. L. Control of synthesis and wastage of ribosomal RNA in lymphocytes. Nature (Lond.), 227: 1105-1107, 1970.
37. Houge, G., Robaye, B., Eikhom, T. S., Golstein, J., Mellgren, G., Gjertsen, B. T., Lanotte, M., and Doskeland, S. O. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol. Cell. Biol., 15: 2051-2062, 1995.
38. Nadano, D., and Sato, T. A. Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement. J. Biol. Chem., 275: 13967-13973, 2000.
39. (2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol., 20: 617-627, 2000.
40. Birnbaum, G. I., Lassota, P., and Shugar, D. 8-Chloroguanosine: solid-state and solution conformations and their biological implications. Biochemistry, 23: 5048-5053, 1984.
41. Jordan, F., and Niv, H. C8-Amino purine nucleosides. A well-defined steric determinant of glycosyl conformational preferences. Biochim. Biophys. Acta, 476: 265-271, 1977.
42. Tavale, S. S., and Sobell, H. M. Crystal and molecular structure of 8-bromoguanosine and 8-bromoadenosine, two purine nucleosides in the syn conformation. J. Mol. Biol., 48: 109-123, 1970.
43. Brentnall, H. J., and Hutchinson, D. W. Preparation of 8-chloroadenosine and its phosphate esters. Tetrahedron Lett., 13: 2595-2596, 1972.
44. Uesugi, S., and Ikehara, M. Carbon-13 magnetic resonance spectra of 8-substituted purine nucleosides. Characteristic shifts for the syn conformation. J. Am. Chem. Soc., 99: 3250-3253, 1977.
45. Stolarski, R., Pohorille, A., Dudycz, L., and Shugar, D. Comparison of theoretical and experimental approaches to determination of conformation of nucleosides about the glycosidic bond. Biochim. Biophys. Acta, 610: 1-19, 1980.
46. Chen, L. S., and Sheppard, T. L. Synthesis and hybridization properties of RNA containing 8-chloroadenosine. Nucleosides Nucleotides Nucleic Acids, 21: 599-617, 2002.
47. Zhang, B., Gojo, I., and Fenton, R. G. Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood, 99: 1885-1893. 2002.
48. Borset, M., Lien, E., Espevik, T., Helseth, E., Waage, A., and Sundan, A. Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. J. Biol. Chem., 271: 24655-24661, 1996.
49. Schwarze, M. M., and Hawley, R. G. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res., 55: 2262-2265, 1995.
50. Tortora, G., di Isernia, G., Sandomenico, C., Blanco, R., Pomatico, G., Pepe, S., Blanco, A. R., and Ciardiello, F. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res., 57. 5107-5111, 1997.
51. McDaid, H. M., and Johnston, P. G. Synergistic interaction between paclitaxel and 8-chloro-adenosine 3′,5′-monophosphate in human ovarian carcinoma cell lines. Clin. Cancer Res., 5: 215-220, 1999.